Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 3
2020 1
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Response to interleukin-1 blockade with anakinra in women and men with ST-segment elevation myocardial infarction.
Corna G, Golino M, Talasaz AH, Moroni F, Del Buono MG, Damonte JI, Chiabrando JG, Mbualungu J, Trankle CR, Thomas GK, Markley R, Canada JM, Turlington J, Agatiello CR, VAN Tassell B, Abbate A. Corna G, et al. Minerva Cardiol Angiol. 2024 Feb;72(1):67-75. doi: 10.23736/S2724-5683.23.06439-6. Epub 2023 Nov 21. Minerva Cardiol Angiol. 2024. PMID: 37987681 Free article.
Response to Interleukin-1 Blockade With Anakinra in Black and White Americans With ST-Segment Elevation Myocardial Infarction.
Corna G, Golino M, Moroni F, Del Buono MG, Talasaz AH, Decotto S, Mbualungu J, Trankle CR, Thomas GK, Markley R, Canada JM, Turlington J, Agatiello CR, Keen L, Van Tassell B, Abbate A. Corna G, et al. Am J Cardiol. 2023 Nov 15;207:336-338. doi: 10.1016/j.amjcard.2023.08.175. Epub 2023 Sep 27. Am J Cardiol. 2023. PMID: 37774475 No abstract available.
Clinical and Pharmacological Implications of Time to Treatment with Interleukin-1 Blockade in ST-Segment Elevation Myocardial Infarction.
Del Buono MG, Damonte JI, Moroni F, Chiabrando JG, Markley R, Turlington J, Trankle CR, Kang L, Biondi-Zoccai G, Kontos MC, Roberts CS, Van Tassell BW, Abbate A. Del Buono MG, et al. J Pharmacol Exp Ther. 2023 Aug;386(2):156-163. doi: 10.1124/jpet.123.001601. Epub 2023 Apr 10. J Pharmacol Exp Ther. 2023. PMID: 37037651
Comparison of Safety and Biological Efficacy of Anakinra (Kineret) Dispensed in Polycarbonate Plastic versus Borosilicate Glass Syringes: A Patient-Level Analysis of VCUART2 and VCUART3 Clinical Trials.
Talasaz AH, Sculthorpe R, Pak M, Lipinski M, Roberts C, Markley R, Trankle CR, Canada JM, Wohlford GF, Golino M, Dixon D, Van Tassell BW, Abbate A. Talasaz AH, et al. J Pharmacol Exp Ther. 2023 Aug;386(2):138-142. doi: 10.1124/jpet.122.001404. Epub 2023 Mar 3. J Pharmacol Exp Ther. 2023. PMID: 36868827 Clinical Trial.
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials.
Abbate A, Wohlford GF, Del Buono MG, Chiabrando JG, Markley R, Turlington J, Kadariya D, Trankle CR, Biondi-Zoccai G, Lipinski MJ, Van Tassell BW. Abbate A, et al. Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):503-510. doi: 10.1093/ehjcvp/pvab075. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34617567 Free PMC article.
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.
Abbate A, Trankle CR, Buckley LF, Lipinski MJ, Appleton D, Kadariya D, Canada JM, Carbone S, Roberts CS, Abouzaki N, Melchior R, Christopher S, Turlington J, Mueller G, Garnett J, Thomas C, Markley R, Wohlford GF, Puckett L, Medina de Chazal H, Chiabrando JG, Bressi E, Del Buono MG, Schatz A, Vo C, Dixon DL, Biondi-Zoccai GG, Kontos MC, Van Tassell BW. Abbate A, et al. J Am Heart Assoc. 2020 Mar 3;9(5):e014941. doi: 10.1161/JAHA.119.014941. Epub 2020 Mar 3. J Am Heart Assoc. 2020. PMID: 32122219 Free PMC article. Clinical Trial.
14 results